Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  9/3/2013
St. Petersburg Sleep Disorders Center
mi
from
St. Petersburg, FL
Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 9/3/2013
St. Petersburg Sleep Disorders Center
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  9/3/2013
Sleep Medicine Associates of Texas (SMAT)
mi
from
Dallas, TX
Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 9/3/2013
Sleep Medicine Associates of Texas (SMAT)
mi
from
Dallas, TX
Click here to add this to my saved trials
Early Indicators of Chronic Rejection in Lung Transplant
Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.
Status: Enrolling
Updated:  9/4/2013
University of Chicago
mi
from
Chicago, IL
Early Indicators of Chronic Rejection in Lung Transplant
Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.
Status: Enrolling
Updated: 9/4/2013
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Early Indicators of Chronic Rejection in Lung Transplant
Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.
Status: Enrolling
Updated:  9/4/2013
University of Chicago
mi
from
Chicago, IL
Early Indicators of Chronic Rejection in Lung Transplant
Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.
Status: Enrolling
Updated: 9/4/2013
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
To Determine if a Lower Extremity Strengthening Program Improve Quadriceps Muscle Strength
Does The Lower Extremity Resistance Program Improve Quadriceps Strength, Endurance, And Quality Life In Pre-Lung Transplant Patients?
Status: Enrolling
Updated:  9/4/2013
University of Chicago Medical Center
mi
from
Chicago, IL
To Determine if a Lower Extremity Strengthening Program Improve Quadriceps Muscle Strength
Does The Lower Extremity Resistance Program Improve Quadriceps Strength, Endurance, And Quality Life In Pre-Lung Transplant Patients?
Status: Enrolling
Updated: 9/4/2013
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Little Rock, AR
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Long Beach, CA
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigational Site
mi
from
Orange, CA
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
San Diego, CA
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis
mi
from
Denver, CO
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis
mi
from
Denver, CO
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Jacksonville, FL
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Atlanta, GA
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Oak Lawn, IL
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
St. Louis, MO
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Omaha, NE
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Las Vegas, NV
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Long Branch, NJ
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Long Branch, NJ
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Morristown, NJ
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Morristown, NJ
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Akron, OH
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Akron, OH
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Cleveland, OH
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Oklahoma City, OK
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Oklahoma City, OK
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigational Site
mi
from
Charleston, SC
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Columbia, SC
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Columbia, SC
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative site
mi
from
Dallas, TX
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Fort Worth, TX
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Houston, TX
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis
mi
from
San Antonio, TX
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Spokane, WA
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative Site
mi
from
Tacoma, WA
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigative site
mi
from
Madison, WI
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigative site
mi
from
Madison, WI
Click here to add this to my saved trials
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/18/2013
Novartis Investigator Site
mi
from
Milwaukee, WI
Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/18/2013
Novartis Investigator Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-2
Status: Enrolling
Updated:  9/25/2013
HealthPartners Institute for Education and Research
mi
from
Saint Paul, MN
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-2
Status: Enrolling
Updated: 9/25/2013
HealthPartners Institute for Education and Research
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study A
Mechanisms of Pharyngeal Collapse in Sleep Apnea
Status: Enrolling
Updated:  9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study A
Mechanisms of Pharyngeal Collapse in Sleep Apnea
Status: Enrolling
Updated: 9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
Status: Enrolling
Updated:  9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
Status: Enrolling
Updated: 9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B
Status: Enrolling
Updated:  9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B
Status: Enrolling
Updated: 9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C
Status: Enrolling
Updated:  9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C
Status: Enrolling
Updated: 9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
The Effects of Trazodone on Sleep Apnea Severity
The Effects of Trazodone on the Severity of Obstructive Sleep Apnea
Status: Enrolling
Updated:  9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
The Effects of Trazodone on Sleep Apnea Severity
The Effects of Trazodone on the Severity of Obstructive Sleep Apnea
Status: Enrolling
Updated: 9/25/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  9/26/2013
Cleveland Clinic Florida
mi
from
Weston, FL
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 9/26/2013
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  9/26/2013
Mayo Clinic
mi
from
Jacksonville, FL
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 9/26/2013
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  9/26/2013
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 9/26/2013
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
University of Arizona College of Medicine
mi
from
Tucson, AZ
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
University of Arizona College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
National Jewish Health
mi
from
Denver, CO
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
Emroy University
mi
from
Atlanta, GA
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
Rush University Medical Center/Stroger Hospital
mi
from
Chicago, IL
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Rush University Medical Center/Stroger Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated:  10/11/2013
Children's Hospital - Boston
mi
from
Boston, MA
Individualized Therapy For Asthma in Toddlers
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials